CHATSWORTH, Calif. — Nutritional supplement maker Natrol Inc. has closed its agreement to be acquired by Aurobindo Pharma USA Inc. (APUSA) for $132.5 million.

Natrol said late Monday that APUSA, a subsidiary of India-based generic drug and active pharmaceutical ingredient maker Aurobindo Pharma Ltd., emerged as the leading bidder for assets of Natrol and Natrol’s subsidiaries, including Natrol’s nutraceuticals brands in the United States, manufacturing assets, personnel and commercial infrastructure.

Executives said the completion of the sale creates a fully integrated nutraceuticals platform in the United States and other global markets.

"I am pleased that Aurobindo recognizes the value of Natrol’s uncompromised quality products, loyal customers, talented employees and solid relationships with our retailer partners. We look forward to working with the Aurobindo team to further expand our over-the-counter product portfolio and our reach with the financial support of strong owners," stated Mesrop Khoudagoulian, Natrol chief executive officer.

"We said at the outset of the restructuring that we would have the right answers within six months, and we have met that timetable to the day," Khoudagoulian added. "I want to thank everyone who has stood by us faithfully during this period, including our vendors, employees, and retail partners. Your loyalty has helped Natrol to achieve its most profitable year to date."

Chatsworth, Calif.-based Natrol manufactures and markets herbs and botanicals, multivitamins, and specialty and sports nutrition supplements to support health and wellness throughout all ages and stages of life. It’s U.S.-made products are available in health food stores, drug stores, supermarkets and mass market retailers, as well as through Natrol.com and other online retailers.

"Natrol comes with certain well-established brands and an extensive distribution network consisting of retail pharmacy chains and specialty health food stores," commented N. Govindarajan, managing director of Aurobindo. "The acquisition of Natrol’s assets will help us tactically position ourselves in the U.S. nutraceuticals spaces and offer an effective growth strategy to expand market penetration going forward."

Natrol added that it’s in the process of opening a new manufacturing facility near its Chatsworth headquarters. The company said proprietary machinery continues to arrive as it moves to complete the assembly process. The new facility will result in the hiring of 100 new employees.